Hereditary dysfibrinogenemia is a rare disorder wherein an inherited abnormality in fibrinogen structure may result in defective fibrin function and/or structure. Congenital hypofibrinogenemia is a rare autosomal bleeding disorder, either recessive or dominant, characterized by a low fibrinogen plasma level. A 28-year-old asymptomatic woman (fibrinogen Rokycany) and a 54-year-old man with thrombosis and pulmonary embolism (fibrinogen Znojmo) were investigated for a suspected fibrinogen mutation after abnormal coagulation tests results were obtained. DNA sequencing showed the heterozygous point mutation Bβ Asn351Lys in fibrinogen Rokycany and the heterozygous point mutation Bβ Arg237Ser in fibrinogen Znojmo, respectively. The kinetics of fibrinopeptide release was found to be normal in both cases. Fibrinolysis was impaired in the Znojmo variant. The average fibril diameters of Znojmo fibrin was slightly increased, but not differing significantly from normal; formed by less fibrils with abrupt fibril terminations. Rheological studies revealed a softer clot. Rokycany fibrin was formed by significantly narrower fibrils than normal fibrin; and the clot was denser than the control clot. Rheological studies revealed a stiffer clot. Impaired fibrinolysis and abnormal clot morphology may be the cause of thrombotic episodes in the patient with Znojmo mutation. New cases of hypofibrinogenemia and dysfibrinogenemia, found by routine coagulation testing, were genetically identified as a novel fibrinogen variants Bβ Asn351Lys (fibrinogen Rokycany) and Bβ Arg237Ser (fibrinogen Znojmo), respectively.

Institute of Hematology and Blood Transfusion U Nemocnice 1 128 20 Praha 2 Czech Republic

Zobrazit více v PubMed

Acta Haematol. 2008;120(2):75-81 PubMed

Eur J Haematol. 2007 May;78(5):410-6 PubMed

J Thromb Haemost. 2009 Feb;7(2):355-9 PubMed

Biochem Biophys Res Commun. 2009 Jan 16;378(3):662-7 PubMed

Biochim Biophys Acta. 2003 Feb 21;1645(2):146-51 PubMed

Nucleic Acids Res. 1988 Feb 11;16(3):1215 PubMed

Thromb Haemost. 2001 Mar;85(3):450-3 PubMed

J Thromb Haemost. 2005 Oct;3(10):2347-9 PubMed

Blood. 2009 Aug 27;114(9):1929-36 PubMed

J Thromb Haemost. 2006 May;4(5):1134-6 PubMed

Blood. 2000 Feb 15;95(4):1336-41 PubMed

Thromb Haemost. 2009 Sep;102(3):479-86 PubMed

Haemophilia. 2008 May;14(3):630-3 PubMed

J Clin Invest. 1995 Dec;96(6):2854-8 PubMed

Blood. 2003 Dec 15;102(13):4413-5 PubMed

Thromb Res. 2007;121(1):75-84 PubMed

J Biol Chem. 1996 Nov 1;271(44):27942-7 PubMed

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):1086-9 PubMed

J Biol Chem. 1993 Apr 25;268(12):8919-26 PubMed

J Mol Biol. 1989 Apr 20;206(4):759-77 PubMed

Nature. 1997 Oct 2;389(6650):455-62 PubMed

J Biol Chem. 1996 Oct 4;271(40):24544-50 PubMed

Biochim Biophys Acta. 1968 Jun 26;160(2):280-3 PubMed

Haematologica. 2006 May;91(5):628-33 PubMed

Glycobiology. 2005 Feb;15(2):153-64 PubMed

Liver. 1992 Dec;12(6):357-62 PubMed

Ann N Y Acad Sci. 2001;936:480-95 PubMed

Ann N Y Acad Sci. 2001;936:89-90 PubMed

J Thromb Haemost. 2003 Jun;1(6):1251-7 PubMed

Structure. 1997 Jan 15;5(1):125-38 PubMed

Structural and Functional Characterization of Four Novel Fibrinogen Mutations in FGB Causing Congenital Fibrinogen Disorder